Ampersand Capital Partners, a private equity firm focused on growth equity investments in life sciences and healthcare, has acquired CurTec, a Netherlands-based manufacturer of high-performance plastic packaging for pharmaceutical and specialty chemical applications. This acquisition was made in collaboration with Bencis Capital Partners and CurTec’s management.
CurTec, headquartered in Rijen, operates manufacturing facilities in the Netherlands and the U.S. and has sales offices across Europe, North America, and Asia. The company designs GMP-compliant, UN-certified packaging solutions for the secure storage and transport of active pharmaceutical ingredients (APIs) and other sensitive products.
Recently, CurTec expanded by opening a new facility in Westminster, South Carolina, enhancing its capacity to serve the growing North American market. With over 300 global customers in the pharmaceutical and specialty chemicals industries, CurTec continues to lead the way in sustainable GMP packaging solutions, exemplified by its Fold Pack product, which enhances supply chain efficiency.
KEY QUOTES:
“We are thrilled to welcome Ampersand as our new partner as we focus on scaling U.S. operations, advancing product innovation, expanding our footprint and growing into adjacent markets. Their deep expertise in the life sciences supply chain and their US network will help accelerate our global presence while reinforcing our commitment to quality, innovation, and sustainability.”
Bart van Berkel, CEO of CurTec
“CurTec is a premium brand trusted by leading pharmaceutical companies – including those within Ampersand’s portfolio – for its exceptional product quality and regulatory standards. We look forward to working closely with Bart and his team to expand capacity, strengthen commercial capabilities, and support long-term growth.”
Hidde Van Kerckhoven, Principal at Ampersand
“We look back on a very successful partnership with CurTec and the team, evolving into a global leader in regulated packaging through innovation, operational and ESG excellence, and a clear focus on pharma. It’s been a pleasure supporting CurTec over all those years together with Fred Lammers, the former CurTec CEO, and we wish the team and Ampersand continued success in this next chapter.”
Zoran van Gessel, Managing Partner at Bencis
